IP in Healthcare 2015

February 2015


HGF are holding a conference which brings together the nuances of intellectual property issues in the pharmaceuticals, life sciences and medical technologies sector under the banner of IP in Healthcare. The conference is the first in the market to focus is on collaborative partnerships, exit strategies for investors, SPCs and data exclusivity, litigation trends and branding in the sector. 

The effective management of and exploitation of intellectual property in the UK’s healthcare market with sectors such as biotechnology, pharmaceuticals, medical technologies is a crucial aspect of any R&D programme. In the UK this sector has in excess of £49.7 bn of turnover and in pharmaceuticals alone approximately £11.5 million is spent every day on R&D.

The sector dynamics are  complex with the role of the NHS in the UK and a network of  universities, research organisations, spin outs and start-ups, SME’s , generics companies and the dominant global pharmaceutical and medical companies all working in collaborations towards solving the worlds fast changing healthcare needs whilst also competing in a fiercely competitive market place. The importance of a robust and clear IP strategy is essential for all organisations to ensure that they are able to use their IP assets to create value to their organisation and offset the costs during R&D and the long pipeline process in bringing their product through regulatory approval and to market.

The conference will be held at The Royal Society of Chemistry, Burlington House, London, W1J 0BA on Wednesday 25th February 2015.

The conference is free to attend and will attract 3 CPD hours.

If you would like to attend please contact Liz Renn or call 0113 233 0189.

Please click here to view the full programme.

About the HGF Healthcare Team

The HGF Healthcare team provides professional expertise and commercially focused advice to business leaders and decision makers in healthcare fields of biotechnology, pharmaceuticals and medical technologies. The firm has in-depth knowledge of the sector, and the experience to provide you with high quality and commercially focused advice in relation to the protection of your IP rights.

The team offers the full range of IP services including:

  • IP strategy and advice
  • Patent and trade mark procurement
  • IP portfolio management
  • Freedom-to-operate advice and opinions
  • IP due diligence assessments and opinions
  • Supplementary protection certificates (SPCs) and data exclusivity advice
  • IP licenses and agreements
  • IP disputes management and litigation

The healthcare team works across the spectrum of organisations in the sector including universities, research organisations, spin outs and start-ups, SME’s, generics companies and the dominant global pharmaceutical and medical companies. Our client base continues to develop and grow by recommendation.

The firm are also active participants in Medilink, AstraZeneca BioHub, PraxiUnico, BioCity Glasgow and the Sheffield City Region LEP Healthcare Technologies Sector Group. We also attend MEDTEC UK and BIO, and provide regular speakers for C5 events.